Skip to main content
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

COVID-19 In Vitro Diagnostic Medical Device - detail

Covid19Check-NAS

Manufactured by Multi-G bvba, Belgium - www.covid19check-mg.com 

Device identification number
2260
CE Marking
Yes
HSC common list (RAT)
Yes
Format
Manual
Physical Support
Cassette, Lateral flow
Target type
Antigen
Targets
nucleocapsid protein
Specimen
Nasal swab
Cross-reactivity (pathogens tested)
SARS-CoV
Lineages detected
A.23.1, AT.1, B.1.1.7 (Alpha), B.1.351 (Beta), B.1.427 (Epsilon), B.1.429 (Epsilon), B.1.525 (Eta), B.1.526 (Iota), B.1.526.1, B.1.526.2, B.1.616, B.1.617.1 (Kappa), B.1.617.2 (Delta), B.1.617.3, B.1.621 (Mu), C.36, C.37 (Lambda), P.1 (Gamma), P.2 (Zeta), P.3 (Theta)
Commercial Status
Commercialised
Last Update
2022-08-24 09:08:01 CET
Comments
All additional data is available on demand. This test is validated by the Belgian Health agency : https://www.famhp.be/en/human_use/health_products/medical_devices_accessories/covid_19/tests
Assay Type
Immuno-Antigen
Rapid Diagnostic
Yes
Reader Required
No
Method
Immunochromatography
Measurement
Qualitative
Time
15 minutes
Subclass
Sandwich, Double
LOD
1600 AU
Calibration
Not evaluated
Analysis of cross reactivity
Evaluated
False positives
0.5 % ( (NPA 99.5%))
False negatives
3 % ( (PPA 97%, 99.35% for Ct values ≤25))
Precision
Evaluated
Accuracy
98.97 %
Reproducibility
Evaluated
Robustness
Evaluated
Clinical Sensitivity
97 % ( (99.35% for Ct values ≤25))
Clinical Specificity
99.5 %
Type of antigen
Nucleoprotein

The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements